Text
The collaboration with ADM a premier global human and animal nutrition company will combine cutting-edge technologies to the pipeline of microbiome-focused innovation from Gnubiotics.
Recurrent UTIs are in part caused by alterations of the gut microbiota and different immune response to bacterial bladder colonization.
New research suggests that hypothalamic neurons use muropeptides as a measure of food intake or of imbalances in the gut microbiota.
New research suggests that the gut microbiota protects the femoral head through the production of extracellular vesicles.
New research suggests that B. infantis can be used to treat children with acute malnutrition.
New research suggests that restoring the gut microbiota’s capacity to sense dietary signals mediated by specific host factors may improve metabolic problems.
Harnessing the human-microbial synergy during pregnancy in the form of probiotics has been shown to impact maternal health and the health of the developing fetus.
The solutions will aim to improve the diagnosis of diseases thanks to a more detailed analysis of the intestinal, oral, ocular, cancer or pulmonary microbiomes.
The virome might be used in therapeutic approaches: eliminating or replacing disease-driving intestinal viruses with health-promoting viruses may be beneficial for people with IBD.
The crowdfunding phase is open, you can preorder the book from 12 USD as e-book or 24 USD as paperback.
